Roundup settlement Bayer, Digimart Global (United States): Bayer has agreed to pay billions of dollars to people who sued the company, alleging that its weed-killer Roundup caused their cancer. On Friday, a judge in Missouri gave final approval to the nationwide settlement, which could cost the company up to $7.25 billion in the coming years, according to NPR.
The money will go to thousands of people who have been or will be diagnosed with non-Hodgkin lymphoma, a blood cancer that claimants link to glyphosate, the main ingredient in Roundup. Under the settlement in circuit court, affected people could receive between $10,000 and $165,000. The amount depends on whether their agricultural or other work exposed them to higher levels of glyphosate, the age at which they were diagnosed and other factors.
Bayer CEO Bill Anderson called the settlement a “decisive milestone” that will “mitigate the risks” of pending and future litigation. Presiding judge Timothy Boyer said it was “among the largest in the history of mass tort personal-injury class action settlements.” The plaintiffs’ attorney, Christopher Seeger, said the order “delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice.”
The new agreement comes on top of an earlier settlement in which Bayer agreed to pay between about $10 billion and $11 billion to resolve more than 100,000 Roundup-related claims. Earlier this year, the U.S.
Supreme Court ruled in Bayer’s favor, finding that it could be shielded from state-court lawsuits alleging it failed to warn consumers about glyphosate’s cancer-causing effects.
The scientific and regulatory picture remains contested. More than a decade ago, the World Health Organization’s cancer agency concluded that glyphosate is probably carcinogenic to humans, and some environmental health scientists have echoed those concerns as recently as this year.
Bayer has consistently denied that its product causes cancer. The Environmental Protection Agency has said it “did not identify risks of concern from glyphosate uses, including for cancer,” but is currently reviewing the evidence related to human health.
Glyphosate safety has been an issue for supporters of Health Secretary Robert F. Kennedy Jr.
and his Make America Healthy Again agenda. The Trump administration, however, has backed the herbicide maker, siding with Bayer in the Supreme Court case and issuing an executive order to promote domestic glyphosate production.
Several years ago, the company removed glyphosate from its U.S. residential products, though it remains in use in agriculture.














